# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-19-005326
Filing Date
2019-08-08
Accepted
2019-08-08 16:08:16
Documents
53
Period of Report
2019-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-Q | f10q_080819p.htm | 10-Q | 595117
2 | EXHIBIT 10.1 | exh_101.htm | EX-10.1 | 132923
3 | EXHIBIT 31.1 | exh_311.htm | EX-31.1 | 9275
4 | EXHIBIT 31.2 | exh_312.htm | EX-31.2 | 9605
5 | EXHIBIT 32.1 | exh_321.htm | EX-32.1 | 4204
6 | EXHIBIT 32.2 | exh_322.htm | EX-32.2 | 4035
13 | GRAPHIC | exh101_header.jpg | GRAPHIC | 5415
14 | GRAPHIC | exh101_footer.jpg | GRAPHIC | 3233
| Complete submission text file | 0001171843-19-005326.txt |  | 4248387

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL INSTANCE FILE | bcrx-20190630.xml | EX-101.INS | 753935
8 | XBRL SCHEMA FILE | bcrx-20190630.xsd | EX-101.SCH | 49879
9 | XBRL CALCULATION FILE | bcrx-20190630_cal.xml | EX-101.CAL | 36929
10 | XBRL DEFINITION FILE | bcrx-20190630_def.xml | EX-101.DEF | 359771
11 | XBRL LABEL FILE | bcrx-20190630_lab.xml | EX-101.LAB | 336047
12 | XBRL PRESENTATION FILE | bcrx-20190630_pre.xml | EX-101.PRE | 371577

Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23186 | Film No.: 191009541
SIC: 2836 Biological Products, (No Diagnostic Substances)